FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Bill to Ban Tianeptine as a Supplement

[ Price : $8.95]

Sens. Durbin and Blumenthal introduce legislation to authorize FDA to ban the marketing of tianeptine, currently being sold as a d...

Thoratec Recalls HeartMate 3 and LVAS Implant Kit

[ Price : $8.95]

Abbotts Thoratec unit recalls its HeartMate 3 and left ventricular assist system implant kit due to the potential for a leak.

Apple Watch Qualified for AFib Trial Monitoring

[ Price : $8.95]

CDRH qualifies the Apple Watchs Atrial Fibrillation History Feature as a medical device development tool for use as a biomarker te...

Info Collection on New Animal Drug Regs

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension entitled New Animal Drugs for Investigational U...

Praise, Suggestions for Informed Consent Guide

[ Price : $8.95]

Five stakeholders generally praise FDA efforts in a draft guidance on key information and facilitating understanding in informed c...

Decentralized Trials Time Has Come: Marks

[ Price : $8.95]

CBER director Peter Marks and Brown University medical school professor Eli Adashi say it appears that decentralized clinical tria...

NCPA Statement to FDA Compounding Session

[ Price : $8.95]

The National Community Pharmacists Association raises several categories of concerns with FDA in advance of the agencys annual dru...

FDA Recognizes Blood Labeling Standard

[ Price : $8.95]

FDA publishes a guidance recognizing the latest revision of the United States Industry Consensus Standard for the Uniform Labeling...

Final Rule on Lab-Developed Tests

[ Price : $8.95]

Federal Register notice: FDA publishes a final rule to amend its regulations to make explicit that in vitro diagnostic products (I...

Use Accelerated Approval for Rare Diseases: Commentary

[ Price : $8.95]

A National Mucopolysaccharidoses Society commentary urges FDA to use accelerated approval for promising treatments for rare diseas...